keine Finanzberatung

CGC · Canopy Growth Corporation

Canadian cannabis producer pivoting to European medical markets

Risiko 9/10 · EXTREME RISK · takeover-hope cannabis · $0.97 ▼ 0.02%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $0.97
  • Market cap $462.6M
  • P/E (ttm) n/a
  • Div yield none
  • 52-wk range $0.84 – $2.38

Wichtigste Risiken

  • Ongoing losses with a levered balance sheet (Shareholders) — EXTREME
  • Further dilution to fund the pivot (Shareholders) — EXTREME
  • US federal legalization never materializes (Shareholders) — HIGH
  • Canadian price compression and oversupply (Shareholders) — HIGH

Fazit

Survives on takeover hope and cost cuts; the operating business alone does not justify the wait.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.